RxDoctor Payments Data

Tracie Vaughan, NP

Family · Galax, VANPI 1811353261

Payments from drug & device makers

$810in general payments, 2019–2025

Across 55 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$353
  • Astellas Pharma US Inc$168
  • Urovant Sciences Inc$149
  • Bayer$32
  • Blue Earth Diagnostics$29
  • AbbVie$26
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$74993%
  • Education$617%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$810 in reported general payments places this provider in the 65th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$102,278
Medicare patients
624
Services billed
10,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron187$132,136
MyrbetriqMirabegron155$89,292
Tamsulosin Hcl595$5,233
Mirabegron ErMirabegron12$5,092
Finasteride344$3,987
Fesoterodine Fumarate ErFesoterodine Fumarate16$3,076
Cephalexin360$2,065
Estradiol28$1,881
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst88$1,459
Silodosin11$1,373
Oxybutynin Chloride ErOxybutynin Chloride77$1,361
Oxybutynin Chloride51$1,277
Solifenacin Succinate52$896
Dutasteride13$674
Ciprofloxacin Hcl68$253

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$353$132,136187 claims
Astellas Pharma US IncMyrbetriq$168$89,292155 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,332 family providers in Virginia.

Other family in Galax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →